BeiGene, Ltd. Quarterly Costs and Expenses in USD from Q2 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
BeiGene, Ltd. quarterly/annual Costs and Expenses history and growth rate from Q2 2015 to Q2 2024.
  • BeiGene, Ltd. Costs and Expenses for the quarter ending June 30, 2024 was $898M, a 9.81% increase year-over-year.
  • BeiGene, Ltd. Costs and Expenses for the twelve months ending June 30, 2024 was $3.52B, a 19.5% increase year-over-year.
  • BeiGene, Ltd. annual Costs and Expenses for 2023 was $3.29B, a 12.6% increase from 2022.
  • BeiGene, Ltd. annual Costs and Expenses for 2022 was $2.92B, a 19.1% increase from 2021.
  • BeiGene, Ltd. annual Costs and Expenses for 2021 was $2.45B, a 24.6% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $3.52B $898M +$80.2M +9.81% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $3.44B $888M +$151M +20.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $3.29B $816M +$254M +45.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $3.03B $915M +$89.3M +10.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.94B $818M +$37M +4.74% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $2.91B $737M -$12.6M -1.69% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $2.92B $562M -$58.6M -9.43% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $2.98B $826M +$157M +23.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.82B $781M +$156M +25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $2.66B $750M +$214M +40% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $2.45B $621M +$35.8M +6.12% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $2.41B $669M +$138M +25.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.28B $625M +$200M +47.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $2.08B $536M +$110M +25.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $1.97B $585M +$140M +31.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $1.83B $531M +$169M +46.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.66B $425M +$95.3M +29% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $1.56B $426M +$174M +69.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1.39B $445M +$105M +31.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $1.28B $362M +$157M +76.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.13B $329M +$113M +52.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.01B $252M +$108M +75.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $904M $339M +$218M +178% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $686M $205M +$100M +95% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $586M $216M +$158M +272% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $429M $143M +$91.8M +178% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $337M $122M +$84.7M +227% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $252M $105M +$70.5M +202% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $182M $58M +$33M +132% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $149M $51.5M +$30.5M +145% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $118M $37.3M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $34.8M +$19.5M +127% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $25M +$17.1M +215% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $21M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q3 2015 $15.4M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $7.95M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.